Healthcare Industry News: AllianceRx Walgreens Prime
News Release - May 19, 2020
AllianceRx Walgreens Prime One of Only Two Specialty Pharmacies to Distribute Vyepti(TM), the First and Only Intravenous Preventive Treatment for MigraineNew medicine one of several limited distribution drugs available through specialty pharmacy
ORLANDO, Fla., May 19, 2020 -- (Healthcare Sales & Marketing Network) -- Lundbeck, a global pharmaceutical company specializing in brain diseases, has named AllianceRx Walgreens Prime one of only two specialty pharmacies to distribute its newest medication for the preventive treatment of migraine in adults. The medication, Vyepti™ (eptinezumab-jjmr), is the first and only intravenous preventive treatment for migraine.
"We are pleased that Lundbeck chose AllianceRx Walgreens Prime as one of two partners to offer this new migraine medication," says Tracey James, senior vice president, pharmacy services, at AllianceRx Walgreens Prime. "Because we have a proven track record in supporting other limited distribution drugs with them, we are able to be a true partner that is always willing to collaborate to improve patient outcomes."
In addition, the following limited distribution drugs are available through AllianceRx Walgreens Prime:
- Palforzia™ (Peanut (Arachis hypogaea) Allergen Powder-dnfp), manufactured by Aimmune Therapeutics, is the first approved treatment for patients with peanut allergy.
- Tymlos® (abaloparatide) injection, manufactured by Radius Health, is approved for the treatment of postmenopausal women with osteoporosis at high risk for fracture, and reduces the risk of fracture in postmenopausal women with osteoporosis.
- Vumerity™ (diroximel fumarate), manufactured by Biogen, treats relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.
About AllianceRx Walgreens Prime
AllianceRx Walgreens Prime (alliancerxwp.com) is a specialty and home delivery pharmacy that strives to provide exceptional care throughout a patient's treatment journey with the medications they need every day. Formed in 2017 through a collaboration between Walgreens, one of the nation's largest chain drug stores, and Prime Therapeutics, a leading pharmacy benefit manager, the company offers tools and resources for patients, providers and health plans to deliver the optimal health outcomes. The company is headquartered in Orlando, Fla. and its pharmacies are accredited by several national pharmacy accreditation services.
Source: AllianceRx Walgreens Prime
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.